Expression of MARK2 and MARK4, as well as the interactions of these kinases with tau, were significantly enhanced in AD brains, correlated with the Braak stages of the disease, and were associated with NFTs (Chin et al., 2000; Gu et al., 2013a). The gene discussed is MAPT; the disease is Alzheimer disease.